Market Overview

Amgen Close to Buying Onyx Pharmaceuticals for $125/Share -NY TImes

Related ONXX
How to Prepare for the New Year
UPDATE: Stifel Terminates Coverage on Onyx Pharmaceuticals Following Acquisition by Amgen
Related AMGN
Healthcare ETFs Leading the Pack This Q2 Earnings - ETF News And Commentary
Top 4 Stocks In The Biotechnology Industry With The Highest Revenue
The Tech Industry is Vanishing Before Our Eyes (Fox Business)

The New York Times is reporting that Amgen (NASDAQ: AMGN) is close to a deal to acquire Onyx Pharmaceuticals (NASDAQ: ONXX) for $125 per share. The deal could be announced on Monday, according to sources.

Onyx rejected an offer of $120 per share from Amgen. Onyx Pharmaceuticals closed Friday at $116.96.

Posted-In: NY TimesNews Rumors M&A

 

Related Articles (AMGN + ONXX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters

Benzinga Professional